| Model Number |
2700 |
| Medical Device Problem Codes |
Gradient Increase (1270); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
| Date of Event |
11/02/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Additional manufacturer narrative: bioprosthetic tissue valves can deteriorate with time and eventually fail contributing to regurgitation and/or stenosis.Structural valve deterioration (svd) is the most common reason for bioprosthesis explants and encompasses multiple failure modes, including calcification, non-calcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly.Alternatively, nonstructural dysfunction (nsvd) may also play a role in the development of valvular regurgitation and/or stenosis.The subject device is not available for evaluation as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 21mm 2700 pericardial valve, implanted in the aortic position, underwent a valve-in-valve procedure after an implant duration of approximately 14 years, 10 months due to unknown reasons.The tavr was performed with a 23mm 9750tfx transcatheter valve.No additional information has been provided.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 21mm 2700 aortic valve, implanted in the aortic position, underwent a valve-in-valve procedure after an implant duration of 15 years, 6 months due to severe stenosis.Patient presented with dyspnea and shortness of breath with acute, diastolic heart failure nyha class iv.The tavr was performed successfully with a 23mm 9750tfx transcatheter valve with no complications.Patient stable to cvicu in sinus rhythm for further management.According to the physician, there was no allegation that the surgical valve prematurely failed.
|
| |
|
Additional Manufacturer Narrative
|
|
Manufacturer narrative: the device history record (dhr) was not reviewed as the reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency and/or one was not confirmed through investigation.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Through further investigation, it was determined that the root cause of this event was most likely due to patient related factors.H11 corrected data: based on new information received, this event is no longer considered reportable.
|
| |
|
Search Alerts/Recalls
|